Business post-sale support: Thriving after the transaction

This session focuses on one of the most critical, and often overlooked, stages of the journey: post-sale transition and support.

We’re delighted to welcome Jack Knight, Managing Director of Xiel, a specialist distributor of radiotherapy and nuclear medicine technologies. S&W supported Jack as a shareholder through the successful sale of Xiel to MIS Healthcare, backed by private equity firm H2 Equity Partners. Jack has remained at the helm, continuing to lead and grow the business under private equity ownership.

Jack will share first-hand insights and practical lessons from navigating a private equity transaction and operating under new ownership – offering an honest perspective on what really happens after the deal is done.